ENDOCRINOLOGY WK 3 Flashcards

1
Q

what are the 3 corticosteroids made in the adrenal and what do they do?

A
Corticosteroids
-	Made in cortex of adrenal gland
Mineralocorticoids
-	Salt and water retention (electrolyte and fluid balance)
Glucocorticoids
-	Glucose synthesis
-	Protein and lipid metabolism
-	Inflammation, immune response
-	Cortisol supresses immune system
Adrenal androgens
-	Fetal steroids and growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the 3 main sex steroids made in the gonad and what do they do? and what vitamin is also a steroid

A

1- Androgens
- Growth and function of the male reproductive system
2- Oestrogens
- Growth and function of the female reproductive system
3- Progesterone
- Female menstraul cycle and maintenance of pregnancy

vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do steroid hormones work - classical genomic mechanism

A
  • Travel in blood taken up when bind to cell receptors on outside of cell
  • Make active transcription factor than goe sinto cell and binds to DNA in nucleus – mRNA made = protein synthesis in cytoplasm
  • Slow action (>30 mins – 48hrs)
  • Eg aldosterone-regulated synthesis of kidney epithelial sodium channel subunit – absorption of sodium takes a while
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do steroid hormones work - non-genomic mechanism

A
  • Non-classical receptors, activated by steroid bindingd eg ion channels in the plasma membrane
  • Intra-cellular signalling pathways, eg calcium/inositol
  • Rapid signalling (<1 min)
  • Eg aldosterone vasoconstriction of vascular smooth muscle and endothelial cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how are steroid hormones made

A

Get rid of fatty 6-carbon cholesterol sidechain
- Makes steroid hromone slightly more soluble than cholesterol
Varied addition of substituent at C-17
- Enzyme nomenclature indicated the site of action
- Eg 17-a-hydroxylase introduces a hydroxyl group at C-17
Extra specifity from side chain modification eg C-11
- Enzyme nomenclature indicates site of action
- 11B-hydroxylase introduces hydroxyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the 2 main enzymes involved in steroid synthesis

A
1.	CYTOCHROME P450s (CYPs)
Highly expressed in…
-	Liver (drug detoxification)
-	Organs that synthesise steroids
o	Adrenal cortex
o	Testis, ovary, placenta
-	Cleave or modify the c holesterol side groups – cut off fatty tail
-	Converts cholesterol to pregnelonone
-	27 carbons -> 21 carbons
  1. Steroid dehydrogenases
    Steroid deydrogenases/reductases (usually paired)
    - Interconvert active and inactive forms of steroids
    - Examples 11B-HSD1 – in liver and peripheral tissues
    - Cortisol -> cortisone in kidney
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cortisol metabolism and transport

A

Bound and inactive hormones transported in the plasma
- Synthesis of cortisol in adrenal gland
- Released into circulation
- A lot binds to transport proteins (90+%)
- Levels of free cortisol increase in diseases – appears in urine(measured)
2 routes
- Bound cortisol tranported to target peripheral tissue where they have local effects
- Or recycles through the liver
o Cortisol converted to inactive cortisone in liver
o Cortisone circulates through blood to peripheral target where it’s then reactivated by 11B-HSD1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the inactive form of cortisol called and what hormone can activate it

A

cortisone

11B-HSD1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

where are the adrenal glands found

A
  • Around the 12th thoracic vertebrae
  • Above the kidneys
  • Triangular shaoe ~4g
  • Anatomist call them suprarenal gland
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what 2 systems are the adrenal glands involved in

A
  • Hypothalamic-pituitary-adrenal (HPA) axis (adrenal cortex)

- Neuroendocrine sympathetic nervous system (adrenal medulla)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 2 main divisions of the adrenal and whats made in each place

A

Cortex > 80-90% of normal gland make steroid hormones
- mineralocorticoids
- glucocorticoids
- adrenal andorgens
Medulla > 10-20% of normal gland make catecholamines
- adrenaline
- nonadrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

whats the blood supply to the cortex and medulla of the adrenal

A

Adrenal cortex

  • receives vlood from 30-50 short arteries penetrating the capsule
  • arteries supply subcapsular plexus of arterioles
  • sinisuidal fenestrated capillary network – have holes in them for rapid transmission fo stimuli to cells and products to targets
  • no cell instructure is more than one cell away from capillary gland

Adrenal medulla
- receives long cortical arteries and capillaries from cortex
- medulla and cortex drain via the central medullary vein
o medulla recieves output of cortex
o in fight or fligth repsonse - adrenaline release, cortisol sustains this repsonse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the subdivisions of the adrenal cortex

A
  • zone glomerulosa (ZG)
  • zone fasciculata (ZF)
  • zone reticularis (ZR_
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what area are mineralocorticoids made - what’s the main product and it’s actions

A

Aldosterone – principle mineralocorticoid SALT
- made in zona glomerulosa
- under control of RAS
o regulated by AII and plasma K
- regulates salt and water retention in kidney distal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what area are glucocorticoids made - what’s the main product and it’s actions

A
Cortisol – principle glucocorticoid SUGAR
-	made in zona fasciculata (ZF)
-	low levles in averag ehealthy human – but problem if oevrproduced pathologically
-	under control of HPA axis 
o	regulated by ACTH from pituitary gland
-	regulates lucose homesostasis
-	stress response
-	inflammation, immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what area are adrenal androgens made - what’s the main product and it’s actions

A

adrenal androgens - DHEA SEX
- made in zona reticularis
- also under control of HPA axis
o also regulated by ACTH from pituitary gland
- co-regulated with glucocorticoid
o if you have excess glucocorticoid you will have excess adrenal androgens
o causes alterations in hair patterns
- intracrine conversion to testosterone and oestradoil in peripheral tissues
- adrenal androgens provide all oestrogen in post-menopausal females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DHEA production - pre and post natal

A
Dehydroepiandrosterone
Prenatal DHEA production
-	role in maintaining oestrogenic environment
-	role in foetal development
Postnatal DHEA production
-	role in intitiation of puberty 
-	main source of andorgens and post-menopasual oestrogen in females?
-	Role in longevity, elixir of life?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what P450s are expressed in each area of the cortex

A

Mineralocorticoid in zona glomerulus…
- Due to aldosterone synthase expression here

Glucocorticoid in zona fasciculata…

  • Due to 17a-hydroxylase
  • Then 11B-hydroxylase

Adrenal andorgens in zona rectularis…

  • Due to 17a-hydorxlase
  • Then 17,20 lysase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

circadian rhythm stress inputs

A
  • Circadian rhytm and stress inputs stimulate CRH release from hypothalamus
  • CRH stimulates ACTH production from pituitary gland (corticophs)
  • ACTH stimulates cortisol production from adrenal zona fasciculata
  • Cortisol feeds back on production of CRH from hypothalamus and ACTH from the anterior pituitary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

diurnal rhythm of plasma cortisol and its regulation

A

Diurnal CRH release regulates ACTH release
- High in early morning
- Lower later in day
ACTH regulates cortisol synthesis
- High on waking
- Lower later in the day (with ‘stress activity spikes)
- Lowest in the middle of the night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cortisol and other molecules that combat low glucose and the dual action of cortisol

A
  • Essential for survival and to resist physiological and environmental stress
  • Part of the ‘counter-regulatory’ hormone defence against hypoglycaemia
  • Levels of these rise as plasma glucose falls-
    o Glucagon from alpha cells of the pancreas
    o Adrenaline
    o Noradrenaline
    o Growth hormone
    o Cortisol (in strarvation aka stress It can maintain plasma glucose)
  • Dual action of cortisol
    o Anabolic in liver to promote gluconeogenesis
    o Catabolic in peripheral muscle and fat to promote protein and lipid breakdown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

anabolic vs catabolic effects of cortisol

A

Anabolic
- Increased gluconeogenesis and liver glucose output
Catabolic
- Inhibittion of glucose uptake by peripheral muscle and fat tissue
- Immune system suppression
- Increased muscle protein breakdown
- Increased fat breakdown
- Increased bone resorption
- Increased appetite and central fat deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

excess cortisol - what are 2 main causes, whats the phenotype

A

Cushing’s disease (pituitary tumour)
Cushing’s syndrome (adrenal or ectopic tumours)

Phenotype – hypertension, low plasma K+, elevated plasma cortisol, low plasma aldosterone and renin activity

Hypertension due to multiple effects of elevated plamsa cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are products of each adrenal cortex layer that contribute to BP contorl

A
zona glomerulus
- aldosterone
zona fasciculata 
- cortisol, corticosterone
zona reticularis
- cortisol, DHEA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are the 3 adrenal hormones systems that regulate BP

A
  • Sympathetic NS
  • RAS
  • HPA axis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how are the 3 main physiological factors that regulate BP affected by steroids from the adrenal

A
Cardiac output
-	Increased by
o	Catecholamines (SNS)
o	Cortisol production (HPA)
Vadcular tone – vasoconstriction
-	Increased by
o	Ang II (AII, RAS)
o	Aldosterone (RAS)
o	Catecholamines (SNS)
o	Cortisol potentiation (HPA)
Extracellular fluid volume
-	Increased by
o	Aldosterone (RAS)
o	Cortisol (HPA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what steroid hormones in the adrenal are general causes of endocrine hyper(hypo)tension

A
  • Aldosterone from ZG
  • cortisol or precursors from ZF
  • catecholamines from medulla
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what mechanisms cause renin release int he kidnyes

A
  • JG cell baroreceptor
  • Macula densa Na+ sending
  • Carotid arch baroreceptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what are the short term effects of RAS and aldosterone

A

Vasculature > rapid secs
- Inc. vasoconstriction
- Postural reg. of BP
Adrenal > rapid mins
- Inc. aldosterone synthesis
- Inc. catecholamine synthesis
Kidney > rapidish 6-48hr
- Inc. Na+ and water resorption
- In distal tubule epithelial cells of kidney…
o Aldosterone binds to mineralocorticoid receptor
o Complex migraite from cytoplasm into nucleus = changes in gene expression
o Transcribes new protein ENaC which goes to apical membrane
o Sodium brought into cell through apical membrane (from tubule into blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what are the longterm effects of RAS and aldosterone

A
Vasculature > long term
-	Smooth muscle 
o	Inc. cell hyperplasia
o	Inc. cell hypertrophy
o	Long-lasting change in vascular tone (stiffer)
CNS > long term
-	Inc. thirst
-	Inc. salt appetite
-	Inc. ADH release
Adrenal > longterm
-	Inc. aldosterone synthase enzyme expression
-	Inc. glomerulosa cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Conn’s syndrome - what does it cause, what is it, phenotype, treatment

A
PRIMARY HYPERALDOSTERONE
Conn’s syndrome
o	Unilateral adrenal tumour
o	Aldosterone-producing adenoma
-	Phenotype – 
o	High aldosterone, MR acitvation
o	High Na+, Low K+, ECF expansion
o	Hypertension, low renin (RAS)
-	Treatment – surgical
o	Venous sampling and/or CT scan
o	Unilateral adrenalectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Bilateral adrenal hyperplasia - what does it cause, what is it, phenotype, treatment

A
PRIMARY HYPERALDOSTERONE
Bilateral adrenal hyperplasia
-	Most common form 60-70% of PA
Phenotype
-	Hig aldosterone, MR activation
-	High Na, low K, ECF expansion
-	Hypertension, low renin
Treatment – pharmacological
-	Anti-hypertensive
-	MR antagonists
-	Spironolactone, epierone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

glucocorticoid-remediable aldosteronism (GRA)

A
  • Autosomal dominant genetic disorder (human chromosome 8)
  • ACTH-driven hyperaldosteronism

Genes for Aldo synthase and 11B-OHase are 95% identical in protein-coding regions

  • BUT gene promoters different…
    o Aldo synthase regulated by K+
    o 11B-OHase regulated by ACTH-driven

GRA hydrid gene
o Unequal meiotic exchange leading to…
- 11B-OHase promoter
- Aldo synthase coding region
o So Aldo production regulated by ACTH which is bad because ACTH promoter Is much more active = hyperaldosteronism / hypertension
- Very bad hypertension in childhood - Normally die in young adulthood

phenotype

  • high aldosterone, MR activation
  • High Na, Low K, High ECF
  • hypertension, low renin

Treatments
o Give synthetic glucocorticoids
o Feedback in hypothalamus supressing pituitary ACTH secretion
o Is ENTIRELY TREATABLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

renin-secreting JG cell tumour - what does it cause, phenotypes, treatment

A
endocrine hypertension - SECONDARY HYPERTENSION
Renin-secreting JG cell tumour
-	Renin hyper-secretion, inc. RAAS
-	Severe hypertension
Phenotype
-	High plasma renin, high aldosterone
-	MR activation, high Na, low K
-	ECF expansion, hypetension
Treatment 
-	Surgical removal of tumour/ kidney
35
Q

renal artery stenosis - what does it cause, phenotypes, treatment

A
endocrine hypertension - SECONDARY HYPERTENSION
-	Low perfusion pressure, renin secretion
-	Inc. RAAS – hypertension
Phenotype
-	High plasma renin, high aldosterone
-	MR activation, high Na, low K
-	ECF expansion, hypetension
Treatment
-	Anti-hypertensive 
-	Statins, anti-platelet agents
-	Balloon angioplastsy +/- stent
36
Q

cortisol overproduction as a cause of endocrine hypertension

A

Adrenal tumour (Cushings syndrome) or pituitary tumour (Cushings Disease)
Presentation
- Weight gain, stretch marks, easy brusing, proximal muscle weakness
- Diabetes mellitus (high plasma glucose), mestrual irregularities, depression
Phenotype
- Hypertension due to multiple effects of elevated plasma cortisol
- High cortisol, high Na+, low K+, (=MR activation), low renin and low aldosterone
Cushings syndrome
- Cortisol-secreting adrenal tumour
- ACTH-secreting pituitary tumour

37
Q

how does plasma cortisol cause hypertension

A

1- glucocorticoids inhibit vascular nitric oxide production by eNOS
2- glucocorticoids potentiate catcholamine action in heart and vasculature
3- glucocorticoids can inappropriately activate the kidney MR

38
Q

glucocorticoid hyperactivity as a cause of endocrine hypertension - Apparent mineralocorticoid excess

A
Apparent mineralocorticoid excess
-	autosomal recessive loss of function mutation in 11B-HSD2
-	decreased conversion of cortisol to cortisone
Phenotype
-	high local kidney cortisol, low RAS
-	MR activation, high Na+, low K+
-	ECF expansion, hypertension
Treatment – pharmacological
-	MR antagonists
o	Sprinoolactone, eplerenone
-	Low Na+ diet and K+ supplements
39
Q

drugs and liquorice ingestion as a cause of endocrine hypertension

A
Drugs and liquorice ingestion
-	Carbenoxolone, glycyrrhizinic acid inhibitors of kidney 11B-HSD2
-	Dec. conversion of cortisol to cortisone
Phenotype
-	high local kidney cortisol, low RAS
-	MR activation, high Na+, low K+
-	ECF expansion, hypertension
Treatment – environmental
-	Altered drug treatment
40
Q

pheochromocytoma as a cause of endocrine hypertension

A

Catecholamine-secreting tumour of the adrenal medulla
Adrenaline from the adrenal medulla-
- Freeze, flight and flight response
- Inc. HR, vasoconstriction, peripheral resistance
- Inc. glucagon secretin, dec. insulin secretion
- Inc. glycogen and lipid breakdown
Pheochromocytoma
- Chromaffin cell tumour
- Secrete catecholamine
- Noradrenaline and/or adrenaline
Distinctive but variable symptoms
Palpitations, Headache, Episodic sweating
- Racing heart, anxiety (~50%)
- Hypertension – sustained/paroxysmal (~50%)
- Diabetes mellitus (~40%)
Diagnosis and treament
- 24 hr urinary metanephrines and catecholamines
- A-blockers, B-blockers, surgical resection

41
Q

what hormones are made/ activated in reproductive/peripheral tissue

A

Sex steroids (NOT corticosteroids) are made in reproductive tissues
- Sex steroids are made through exact route in the adrenal gland in other tissues
- Cortisol not made in reproductive tissues but inactive cortisone can be activated by reproductive tissues
o This is why you get cortisone injections in sport injuries as it is activated locally to produce antiinflammatory repsonse

42
Q

what are the 2 types of enzymes involved in sex hormone synthesis

A

1- Cytochrome P450s (CYPs)

a. 17a- OHase and17, 20 lyase (CYP17A1)
i. In adrenal cortex ZR
ii. And testis and ovary
b. Aromatase (CYP19A1)
i. Ovary
ii. AND periphral ostrogen targets eg breast, bone etc
iii. (aromatase inhibitors used to treat cancer)

2- Steroid dehydrogenase

a. Interconvert steroids
i. 3B-HSDs – adrenal, testis, ovary
ii. 17B-HSDs – testis, ovary
iii. 5a-reductass – testis and peripheral tissues

43
Q

testosterone and estradiol production

A
  • DHEA and androstenedione made in BOTH male and female gonads
  • Same pathway as adrenal glands
  • BUT ovaries and testis Leydig cells contain an additional enzyme
  • 17B-hydroxysteroid dehydrogenase-3 (17B-HSD-3)
  • Converts androstenedione (‘pro’) to weak C19 androgen testosterone

In testis sertoli cells 5a-reductase converts testosterone to strong androgen 5a-dihydrotestosterone

In ovary and peripheral tissues, aromatase converts testosterons to strong oestrogen oestradiol (C18)

44
Q

how are sex steroids regulated by the HPG axis

A
  • Gonadotrophin-releasing hormone (GnRH) from HP preoptic nucleus
  • Acts on anterior pituitary gonadotrophs
    o FSH
    o LH
  • FSH and LH stimulate sex steroid hormone production in gonads
    o Andorgens (male)
    o Oestrogens (female)
    o ALSO inhibins (male and female)
  • Hormonal feedback on pituitary and hypothalamus regulate synthesis
45
Q

male sex steroid synthesis in the testis - what cells are involved in synthesis of what hormones, how do the hormones travel through this system

A

Steroidogenic leydig cells – make testosterone
- The triangle area between cells
Sertoli cells – ‘nursery’ cells for sperm production make inhibin and ABP
- The cells themselves
- LH stimulates testosterone production by leydig cells
- FSH promotes inhibin and androgen binding protein (ABG) in sertoli cells
- T moves from leydig to sertoli cells
- T converted to DHT and binds to ABP in luminal of the semineferous tubules
- Need high levels of testosterone and DHT in seminiferous tubules to drive spermogenesis (sperm maturation and production)
Inhibin is a key marker of sertoli cell function

46
Q

how is testosterone transported to peripheral targets and how is this disturbed by drug therapy

A
  • Testosterone transported in plasma to peripheral targets bound (98%) to sex hormone-binding globulin (SHBG)
  • Conc. Of this hormone can be disturbed by drug therapy
    o This effects amount of free testosterone in the body
    o Can make people infertile
47
Q

how does testosterone and inhibin feedback on the HPG axis

A
  • T from leydig cells and inhibin from sertoli cells feedback on GnRH, LH and FSH
48
Q

what are the actions of male sex hormones

A
Androgens (testosterone, 5a-DHT) regulate
-	Primary male reproductive functions eg
o	Spermatogenesis, prostate secretions
-	Secondary male sex characteristics 
o	Anabolic build muscle
o	Deep voice, facial and body hair
o	Brain – libido and aggression
-	Essential during foetal life
o	Male sex determination
o	Genital development
	Testosterone from mother
	Sex-determination gene SRY in males which causes sertoli cell differentiation – allow testis to form and leydig cells to develop leading to testosterone surge at 7-8 weeks, without this foetus wont develop into male phenotypically
49
Q

what is androgen insensitivity syndrome

A

• Functional mutation
• Due to mutated testosterone receptor
• Arrested testis development, lack of testosterone and anti-mullerian hormone
- phenotypically female, genome is XY

50
Q

what does lack of oestrogen in males lead to

A
o	Lack of oestrogen in males … failure to convert testorsterone to oestradiol
	Tall and long arms
	Bone epiphyses did not close
	Loss of bone mass
	Osteoporosis
51
Q

synthesis of female sex steroid hormones in the ovary - what cells are involved, and what is the order of synthesis, what is involved in negative feedback, how are the hormones transported to peripheral targets

A
  • LH stimulates production of androstenedione and testosterone in thecal cells of the primary follicle
  • Androgens move from thecal to granulosa cells
  • FSH stimulates androgen conversion to oestrogens by aromatase
  • Action – estradiol regulates the proliferative phase of the female menstrual cycle
  • Estradiol and inhibin from granulosa cells feed back on GnRH + LH and FSH release from HP and pituitary
  • Estradiol also transported in plasam to peripheral targets bound to gonadal sex hormone-binding globulin (SHBG)
52
Q

oestrogen role

A
  • Female genital development and differentiation
  • Secondary female sex characteristics eg body fat distribution, cardiovascular system, skin, bone, epiphyseal closure
  • Estrogen from the primary ovarian follicle promotes endometrial growth during the follicular or ‘proliferative’ phase
53
Q

progesterone role

A
  • Made in the corpus luteum promotes endometrial secretion and vascularisation during the luteal or ‘secretory’ phase
  • Prepares uterus for implantation of fertilised egg
  • If no egg progesterone falls away = menstuation
54
Q

normal ovarian cycle

A

Follicular (proliferative) phase
- Day 0-14
- FSH and LH stimulate estradiol production by the primary follicle
- Promotes endometrial growth
LH surge triggering ovulation
- Day 14
- Rising estradiol stimulate LH production = the LH surge
- LH surge stimulates ovulation aka follicle ruptue and egg releases
- It’s the egg that makes oestrogen so when lost follicle begin to make progesterone
Luteal (secretory) phase
- Day 14-28
- Corpus luteum makes progesterone
- Receptive secretory environment for implantation of a fertilised egg

55
Q

sex steroid regulation without implantation of egg (day 14-28)

A
  • Corpeus luteum regrasses and stops producing progesterone
  • Declining feedback of
    o Progesterone, oestrogen, inhibin
  • Allows a new cycle of LH and FSH release
56
Q

sex steroid regulation with implantation of egg (day 14-28)

A
  • Developing embryo produces hCG (human chorionic gonadotrophin) an alternative form of LH
  • Does the same as LH – binds to LH receptor and prompts prgesterone to be made
  • hCG binds to LH receptors on corpus luteum and endometrium
    o maintains progesterone secretion
    o inhibits maternal immune rejection of placenta
  • progesterone promotes uterine blood vessels to sustain the growing fetus
57
Q

luteal-placenta shift 7-9 weeks of pregnancy

A

Hormone decline

  • hCG from embryo
  • prgesterone from corpus luteum

to maintain pregnancy, placenta begins to produce;

  • progesterone from cholesterol
  • oestrogen from DHEA (fetal adrenal)
58
Q

primary adrenal insufficiency - addisons disease - causes, presentation, phenotype, treatment

A

Causes

  • destruction of adrenal gland
  • by TB, cancer metastases, autoimmune disease

Presentation

  • disease of all 3 adrenocortical zones
  • aldosterone, cortisol and adrenal androgens all affected

Phenotype

  • low plasma aldosterone = lack of MR activation
  • low Na+, high K+, reduced ECF, hypotension
  • low plasma cortisol, low glucose, high ACTH (lack of cortisol feedback)
  • skin pigmentation (due to high ACTH)

Treatment

  • fluid and hormone replacement
  • synthetic glucocorticoid (hydrocortisone, prednisone)
  • synthetic mineralocorticoid (flucrocortisone)
59
Q

secondary adrenal insufficiency - hypopituitarism - causes, presentation, phenotype, treatment

A

Causes

  • partial or complete loss of anterior lobe pituitary function
  • tumour, pituitary apoplexy, suppression by long-term corticosteroids
  • lack of pituitary ACTH secretion and adrenocortical trophic stimulation

presentation

  • malfunction of ZF and ZR, reduced cortisol and androgen secretion
  • RAS and aldosterone secretion (ZG) largely unaffected

Phenotype

  • Low plasma ACTH and cortisol due to pituitary and adrenal failure
  • Inc. vasopressin release from posterior pituitary
  • ECV expansion low Na+, low K+ (dilutional hyponatraemia)

Treatment

  • Hormone replacement, transsphenoidal decompression/tumour removal
  • Synthetic glucocorticoid (hydrocortisone, prednisone), thyroxine, etc.
60
Q

congenital adrenal hyperplasia - presentation, genetics and phenotype

A

Presentation

  • Inherited condition present at birth (congenital) in which adrenal gland is larger than usual
  • A form of primary adrenal insufficiency
  • Usually caused by a inherited defect in gene for any steroidogenic enzyme
  • Inactivating mutations partial or complete

Genetics
- Autosomal recessive - both parents carriers
- Heterozygote ‘carriers’ usually asymptomatic (may affect immune system)
- Affected individuals usually compound heterozygotes
o Both alleles altered, but different mutations inherited from mother and father
- BUT also see genuine hmozygotes
o Eg consaginous marriages

Phenotype in all CAH syndromes
o	Block cortisol syntheis pathway…
	Reduced cortisol
	Impaired stress response
	Reduced plasma glucose
	Reduced feedback on CRG-ACTH (pituitary and hypothalamus)
o	Due to reduced feedback you get large secretion of CRH and ACTH
	ACTH promotes growth in the adrenal gland
	Adrenal gland grows
o	Also changes in other steroids
	Excess intermediaes before block
	Reduced hormones after block
61
Q

different type of CAH and their frequencies

A

Frequency?

Common (90-95%) cases
o Steroid 21-hydroxylase/ 21-OHase
o Population frequency 1:14,500
o Heterozygous frequency 1:61
o This is due to pseudo gene – 2 21-OHase genes, so corssing over of these is more likely
o Suggestion that mutation is beneficial as lower cortisol is immunologically beneficial

Less common (5% of cases)
o 11b-OHase
o Affects glucocorticoid synthesis but not mineralocorticoid synthesis

Rare (0.1-1% of cases)
o 17a-OHase
o 3B-HSD
o StAR (Lipoid CAH)

62
Q

partial steroid 21-hydroxylase deficiency in ZG and ZF?ZR (CAH) - presentation, treatment and monitoring

A

dec. cortisol, dec. feedback, inc. ACTH
- Symptoms reflect mainly lack of cortisol (enough aldo still made)
o Remember – cortisol is made at 100x higher levels than aldosterone
- Increased androgens
o Virilisation in boys, masculinisation in girls
- Most common cause of ambiguous genitilia due to prenatal masculinisation of genetically female (XX) infants
Treatment
- Replace cortisol function
- Feed-back inhibit ACTH ‘drive’
- Reduce ACTH-driven androgens
Monitoring
- Glucocorticoid replacement
- Monitor 17-OH progesterone
- Androgen levels (most important)

63
Q

complete steroid 21-hydroxylase deficiency in ZG and ZF?ZR (CAH) - presentation, treatment and monitoring

A

dec. cortisol + aldosterone, dec. feedback, inc. ACTH
- Severe classical ‘salt wasting’ form… aldo synthesis also blocked
- Symptoms reflect a lack of cortisol AND aldosterone
o Low plasma aldosterone = lack of MR activation
o Low plasma Na+, high plasma K+, H+ = hyperkalaemic acidosis
o ECF deficit, hypotension and vascular collapse
o Life-threatening vomiting and dehydration in new-borns – treatment essential
- Increased androgens
o Virilisation in boys, masculinisation in girls
Treatment
- Replace cortisol and mineralocorticoid
- Reduce ACTH-driven androgens
- Normalise plasma Na+, ECF and bp
monitoring
- Glucocorticoid replacement
- Monitor 17-OH progesterone
- Androgen levels (most important)

64
Q

general info on 21-hydroxlase deficiency - screening, problems associated with excess androgens if left untreated

A

Screening for common gene mutations in some countries

  • In UK with family history
  • ? introduction in UK – under debate but cost
  • Early intervention in utero improves outcomes
Excess androgen production in females, left untreated
-	Gender mis-assignment
-	Psychological problems
-	May need corrective surgery
Untreated 21-OH CAH 
-	Ambiguous genitalia
-	Single urethral/ vaginal orifice
-	Fused labia and enlarged clitoris
65
Q

late onset 21-OHase deficiency - presentation, treatment, monitoring

A

Late onset 21-OH CAH
- Mild inactivating mutation – less severe than in affected neonates
- Usually presents after puberty in women
- Following upsurge in ACTH and adrenal steroid secretion (adrenarche)
Excess adrenal androgen result in
- Menstrual cycle disturbances
- Polycystic ovarain syndrome and hirsutism
- Possible infertility (key differential diagnosis for PCOS)
Treatment – hydrocortisone replacement
- Replace cortisol function
- Feed-back inhibit ACTH ‘drive’
- Reduce ACTH-driven androgens
Monitoring
- Titrate glucocorticoid replacement
- Monitor 17-OH progesterone and androgen levels

66
Q

11B-hydroxylase deficiency in ZF - hormonal pattern, presentation, treatment, monitoring

A

Affects just glucocorticoid production

Hormonal pattern…

  • Dec. cortisol (partial block), dec. feedback, inc. ACTH
  • Inc. 11b-OH substrates -> deoxycortisol and deoxycorticosterone (DOC) in ZF
  • Excess adrenal androgens
  • Hypertension due to weak mineralocorticoid activity of DOC at the MR (mineralocorticoid receptor) in the kidney

Increased 11B-hydroxylase enzyme substrates
- 11-deoxycortisol
- 11-deoxycorticosterone (DOC) – weak mineralocorticoid (active at the kidney MR, NOT inactivated by 11B-HSD-2)
- Inappropriate MR activation causes Na+ retention, ECF expansion, hypertension, low renin (RAS) and inhibition of aldo production in the ZG
- Hypertension the clinical clue that a pateint has 11OH-CAH (rather than 21-OH CAH)
- Increased andorgens
o Virilisation in boys, masculinisation in girls

Treatment – life-long glucocorticoid replacement

  • Replace cortisol function
  • Feed-back inhibit ACTH ‘drive’
  • Reduce ACTH-driven androgen and mineralocorticoid production

Monitoring

  • Monitor 17-OH progesterone and androgen levels as for 21-OH CAH
  • Also measure plasma Na+ concentration
67
Q

what is the main clinical clue that a patient has 11OH > 21-OH CAH

A
  • Hypertension the clinical clue that a patient has 11OH-CAH (rather than 21-OH CAH
68
Q

what 2 specific stains are used to biopsy neuroendocrine tumours

A

o Chromogranin A and synaptophysin

69
Q

what are carcinoid symptoms associated with NET and what can be measured to assess these

A
  • Flushing and diarhhoea
  • Measure…
    o Urine 5-HIAA
    o Chromogrannin A
70
Q

what is a common hormone produced by NETs - what does it cause and how is it measured

A
  • Can’t measure serotonin in blood
  • Measure downstream metabolite of this 5-Hydroxyindole Acetic Acid
  • Serotonin leads to… flushing, diarrhoea, bronchospasm, right heart failure
  • Often have patients with severe diarrhoea that go undiagnosed for ages
  • Presnet as RHF as serotonin sticks to receptors on right side of heart
  • Flushing during alcohol / social interaction is a sign
71
Q

why is right heart disease associated with NETs

A
  • When you have NET in liver lots of serotonin travelling to the heart
  • Serotonin sticks onto heart valves = valve dysfunction, tricuspid regurgitation
  • Sytmpomts > leg swelling, elevated JVP, ascites
72
Q

clinical characteristics of NETs

A
  • Rare
  • Significant majority arise in GI system (including pancreas)
  • Usually slow growing
  • Wide specturm of disease activity
  • Often metastatic at presentation
  • Prolonged survival is possible
  • Neuroendocrine carcinomas
    o Follow traditonal cancer pathway = poorer diagnosis
  • Neuroencorine tumours ing neeral act differently
    o Grade 1, 2, 3, 4 (carcinoma)
73
Q

presentation of NETs in different body regions

A
-	Liver 
o	pain due to enlargement of capsule
o	abnormal LFTs
-	stomach
o	indigestion
o	iron deficiency anaemia
o	some blood loss
-	appendix
o	appendicitus
o	small apendicial tumour on appendectomy
-	bowels
o	bowel obstruction – abdominal distetnion, vomitting, pain
-	rectal
o	bleeding from rectus
-	pancreas
o	picked up on CT when present with abdominal pain
o	producing hormone – present with symptoms speciifc to hormone
-	lung
o	cough
o	on chest x-ray
74
Q

hormonal presentation of NETs - depending on specific hormone

A
if make hromones present earlier
-	insulin
o	Present with hypoglycaemia
-	Glucagon
o	Present with diabetes
o	Classical rash
-	Gastrin
o	Heart burn
o	Peptic ulcers despite PPIs
-	Vasoactive intestinal polypeptide (VIP)
o	Diarrhoea
o	Hypokalaemia
75
Q

firstline treatment of NETs

A
  • Active surveillance as treatment can make QoL worse
  • Surgery (bowel/ pancreatic/ hepatic)
  • Somatostatin analogue therapy
    o expensive
76
Q

somatostatin analogue mode of action

A
  • get hormonal levels down – dec. serotonin
  • have anti-tumour effecst also
    o reduced cell proliferation
    o dec. rate of change of NET
77
Q

what type of scan can be useful to find metastases in NETs

A

Do a nuclear medicine scan

  • inject radio labelled octreotide
  • taken up by NET
  • is NET lights up you can do specialised treatment to make it better
78
Q

radionuclide therapy for NETs

A
  • because tumour took up ocreotide you can attach radiotherapy to this compund for treatment
  • can target the relatively ischaemic central core of metastic deposits
  • potentially toxic to bone marrow an dkidneys
    In scotland use lutetium
  • slow down rate of change of tumour
  • for hromonally active tumour this can be effective to dec. hormone levels
79
Q

transarterial chemoembolisation for NETs

A
  • injection of small molecules that block blood vessels of tumours and kill the tumours
  • can be given in most large centres
  • only targets cancer deposits in the liver
  • destructive therapy so potential for rapid release of hormones from the dying cells
  • this can cause major mood swings in blood pressure
80
Q

general info about multiple endocrine neoplasia MEN

A

Arises from problem in tumour suppressor genes
- lose ability to stop proliferation
- but resulting proliferation is relatively slow
- can be screened for in childhood if patient had condition
o to pick up tumours that develop
o manage psychological aspects
- autosomal dominant inheritance
- 1:30,000

81
Q

MEN type 1 - what genes affected and what the clinical presentation

A
  • Defect in the MEN1 gene
  • Gene product is menin (TSG)
  • Chromosome 11

Clinical presentation (Ps)

  • Primary hyperparathyroidism
  • Pituitary adenomas
  • Pancreatic tumours
  • Adrenal adenomas
  • Bronchial / thymic carcinoids
  • (lipomas/ angiofibromas)
82
Q

screening for MEN

A
  • Annual calcium and PTH
  • Annual fasting gut hormones
    o Chromogrannin A, insulin-glucose, gastrin glucagon, pancreatic polypeptide
  • 3 yearly MRI of pituitary and now pancreas
  • Consideration for CT/MRI of chest and thymus
83
Q

MEN type 2 - what gene affected and presentation of both MEN 2A and MEN 2B

A
  • Defect in MEN2 gene
  • Gene product is ret
  • Proto-oncogne
  • Chromosome 10
    Many codon mutations that happen in MEN2 gene
  • The codon determines when thyroidectomy is performed to prevent medullary thyroid cancer
2A (85%)
-	Hyperparathyroidism
-	Medullary thyroid cancer
-	Phaeochromocytoma
o	Important because anaesthesia can kill them  due to release of too much adrenaline

2B (5%)

  • Hyperparathyroidism
  • Medullary thyroid cancer
  • Phaechromocytoma
  • Neuromas, fibromas, musculoskeletal abnormalities
  • Marfanoid habitus
84
Q

at what time in foetal development is the ‘jolt of testosterone’ that makes the baby develop into a male, what causes this and what happens without this

A

7-8 wks

  • sertoli cell differentiation from genes on the SRY gene in foetus
  • if this doesn’t happen may develop down a female pathway